chr11-1233015-A-G

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_002458.3(MUC5B):​c.2068A>G​(p.Lys690Glu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00007 in 1,586,486 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.00043 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000032 ( 1 hom. )

Consequence

MUC5B
NM_002458.3 missense, splice_region

Scores

1
7
9

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 6.32

Publications

1 publications found
Variant links:
Genes affected
MUC5B (HGNC:7516): (mucin 5B, oligomeric mucus/gel-forming) This gene encodes a member of the mucin family of proteins, which are highly glycosylated macromolecular components of mucus secretions. This family member is the major gel-forming mucin in mucus. It is a major contributor to the lubricating and viscoelastic properties of whole saliva, normal lung mucus and cervical mucus. This gene has been found to be up-regulated in some human diseases, including sinus mucosa of chronic rhinosinusitis (CRS), CRS with nasal polyposis, chronic obstructive pulmonary disease (COPD) and H. pylori-associated gastric disease, and it may be involved in the pathogenesis of these diseases. [provided by RefSeq, Jul 2010]
MUC5B Gene-Disease associations (from GenCC):
  • interstitial lung disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.028255492).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002458.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MUC5B
NM_002458.3
MANE Select
c.2068A>Gp.Lys690Glu
missense splice_region
Exon 18 of 49NP_002449.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MUC5B
ENST00000529681.5
TSL:5 MANE Select
c.2068A>Gp.Lys690Glu
missense splice_region
Exon 18 of 49ENSP00000436812.1
MUC5B
ENST00000525715.5
TSL:1
n.2126A>G
splice_region non_coding_transcript_exon
Exon 18 of 26

Frequencies

GnomAD3 genomes
AF:
0.000427
AC:
65
AN:
152190
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000112
AC:
24
AN:
214572
AF XY:
0.0000763
show subpopulations
Gnomad AFR exome
AF:
0.00150
Gnomad AMR exome
AF:
0.000155
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000321
AC:
46
AN:
1434178
Hom.:
1
Cov.:
34
AF XY:
0.0000253
AC XY:
18
AN XY:
711616
show subpopulations
African (AFR)
AF:
0.000967
AC:
32
AN:
33100
American (AMR)
AF:
0.0000935
AC:
4
AN:
42784
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25660
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38856
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83706
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
42174
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5746
European-Non Finnish (NFE)
AF:
0.00000272
AC:
3
AN:
1102558
Other (OTH)
AF:
0.000117
AC:
7
AN:
59594
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000427
AC:
65
AN:
152308
Hom.:
0
Cov.:
34
AF XY:
0.000416
AC XY:
31
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.00144
AC:
60
AN:
41560
American (AMR)
AF:
0.000261
AC:
4
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68016
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000551
Hom.:
0
Bravo
AF:
0.000665
ESP6500AA
AF:
0.000469
AC:
2
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000158
AC:
19

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:2
Aug 03, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2068A>G (p.K690E) alteration is located in exon 18 (coding exon 18) of the MUC5B gene. This alteration results from a A to G substitution at nucleotide position 2068, causing the lysine (K) at amino acid position 690 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.

Mar 16, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.Lys690Glu variant in MUC5B has not been previously reported in individuals with pulmonary disease, but has been identified in 0.2% (9/3796) of African chr omosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.o rg; dbSNP rs376986344). Computational prediction tools and conservation analysis suggest that the p.Lys690Glu variant may impact the protein, though this inform ation is not predictive enough to determine pathogenicity. In summary, the clini cal significance of the p.Lys690Glu variant is uncertain.

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.32
CADD
Uncertain
23
DANN
Benign
0.73
DEOGEN2
Benign
0.048
T
Eigen
Uncertain
0.60
Eigen_PC
Uncertain
0.50
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Benign
0.71
T
M_CAP
Uncertain
0.20
D
MetaRNN
Benign
0.028
T
MetaSVM
Benign
-0.68
T
MutationAssessor
Uncertain
2.4
M
PhyloP100
6.3
PrimateAI
Uncertain
0.48
T
PROVEAN
Uncertain
-3.7
D
REVEL
Uncertain
0.30
Sift
Benign
0.038
D
Polyphen
0.99
D
Vest4
0.34
MVP
0.12
ClinPred
0.15
T
GERP RS
4.8
Varity_R
0.43
gMVP
0.69
Mutation Taster
=81/19
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs376986344; hg19: chr11-1254245; API